Quantcast

Latest MRSA Stories

2009-03-20 13:49:00

SAN DIEGO, March 20 /PRNewswire-USNewswire/ -- A rigorous environmental cleaning intervention can reduce the transmission of methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant organisms in hospital intensive care units (ICUs), according to a new study presented today at the annual meeting of the Society for Healthcare Epidemiology of America (SHEA). Researchers found that following an enhanced cleaning protocol reduced the spread of MRSA to patients exposed to...

2009-02-27 06:30:00

Dressing Offers a Highly Effective and Affordable New Option to Help Combat the Escalating MRSA Crisis PRINCETON, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its first BIOGUARD Barrier Dressings have received clearance from the U.S. Food and Drug Administration for marketing and distribution. BIOGUARD will offer surgeons, wound care clinicians, infection control experts and primary...

2008-10-27 09:00:41

WASHINGTON, Oct. 27, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. presented a detailed analysis of CANVAS I, a globally conducted, multi-center, Phase III clinical trial, at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy / Infectious Diseases Society of America 46th Annual Meeting (ICAAC / IDSA) in Washington, DC. The results of this 702 patient study demonstrated that ceftaroline monotherapy achieved its primary endpoint of non-inferiority...

2008-10-26 12:00:10

REINACH, Switzerland, Oct. 26 /PRNewswire-FirstCall/ -- Arpida today presented the combined results from two pivotal Phase III clinical trials at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, DC. In these studies, intravenous iclaprim, a novel antibiotic, showed high clinical cure rates which were similar to those of the comparator drug, linezolid, in the treatment of...

2008-10-20 12:00:32

Taipei, Taiwan -October 20 2008 - TaiGen Biotechnology Co., Ltd. today announced a total of 11 posters on its investigational drug nemonoxacin will be presented at the joint 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / 46th Annual Meeting of Infectious Diseases Society of America (IDSA) to be held in Washington, D.C. from October 25 - 28, 2008. Nemonoxacin, a non-fluorinated quinolone, has an exceptional activity against MRSA...

2008-09-19 21:00:33

THE Prime Minister yesterday hailed a victory in the fight against a deadly superbug as figures showed a 36% fall in MRSA cases in England in the past year. The Health Protection Agency (HPA) figures for April to June showed a 14% decrease in hospital- acquired MRSA infections compared to the previous quarter, and a 36% reduction on the corresponding quarter of 2007. They also showed that the Government's target of halving cases of MRSA in hospitals since 2004 has been exceeded, with a...

2008-09-16 09:00:53

Enanta Pharmaceuticals, a developer of small molecule anti-infective drugs, has initiated a Phase Ia study on investigational oral antibiotic EDP-322, a methicillin-resistant Staphylococcus aureus-active Bicyclolide, a novel macrolide-related drug class with a distinct resistance profile. The Phase Ia, double-blind, placebo controlled study for EDP-322 announced is a single ascending dose trial in healthy volunteers. The clinical development program for EDP-322 will include the treatment...

2008-09-15 09:00:57

WATERTOWN, Mass., Sept. 15 /PRNewswire/ -- Enanta Pharmaceuticals, a leader in the development of small molecule anti-infective drugs, announced today the initiation of a Phase 1 study on investigational oral antibiotic EDP-322, a first-in-class MRSA-active Bicyclolide, a novel macrolide-related drug class with a distinct resistance profile. The clinical development program for EDP-322 will include the treatment of hospital- and community-acquired gram-positive infections, including...

2008-08-04 12:01:30

HUNTSVILLE, Ala., Aug. 4 /PRNewswire/ -- Diatherix Laboratories, an independent clinical reference laboratory located in the Hudson-Alpha Institute for Biotechnology, announced today it has received its Clinical Laboratory Improvement Amendment (CLIA) certificate* for its proprietary licensed testing process, Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR). This molecular differential diagnostic technology is the first Tem- PCR test introduced to the clinical market which is...

2008-07-29 21:00:41

U.S. researchers say they suspect a sharp rise in skin infections is due to methicillin-resistant Staphylococcus aureus, or MRSA. Researchers at the University of California, San Francisco, say data from the National Center for Health Statistics for patient visits for skin infections from 1997 to 2005 show a rise from 8.6 nationwide to 14.2 million. They also report an increase from 4.6 million to 9.6 million in visits for abscesses or cellulitis -- the hallmark sign of infections due to...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related